Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 901–964 of 964
Kany, S., Rillig, A., Metzner, A., & Ouyang, F. O. (2022) · International Journal of Heart Rhythm · doi:10.4103/ijhr.ijhr_7_22
Editorial: Strategies to improve management of ventricular tachycardias
Maass, A. H., Blaauw, Y., Mulder, B. A., & Zeppenfeld, K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1279076
“The topics can be divided into two main sections: improvements in (1) risk stratification and (2) treatment of ventricular tachycardia (VT).”
BackgroundInfluentialLangzeitergebnisse der Katheterablation idiopathischer und struktureller Kammertachykardien
Lucas, P., Sciacca, V., Sommer, P., & Fink, T. (2023) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-023-00964-1
Ventricular arrhythmias: It is the substrate that counts
Ahmad, A., & Doshi, R. N. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.11.018
Ventricular arrhythmias and sudden death in heart failure
Trancuccio, A., Latini, A. C., Arnò, C., Kukavica, D., Mazzanti, A., & Priori, S. G. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198891628.003.0071
Ventrikuläre Herzrhythmusstörungen
Steven, D., Scheurlen, C., Dittrich, S., Filipovic, K., van den Bruck, J., & Sultan, A. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62932-1_4
Ojo, A. O., Tankut, S. S., Prinzi, T., & Huang, D. T.-C. (2023) · In clinical practice · doi:10.1007/978-3-031-41479-4_9
Roukoz, H., & Tholakanahalli, V. N. (2024) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2024.02.002 · Cited by 1
“In this light, catheter ablation is an important adjuvant therapy to decrease the occurrence or recurrence of device therapies and antiarrhythmic medication side effects in patients with drug refractory or drug intolerant VT and electrical storm [2,3].”
BackgroundÜbersicht zur Katheterablation ventrikulärer Arrhythmien
Steven, D., Tscholl, V., Lüker, J., Hättasch, R., Wörmann, J., Attanasio, P., Dagres, N., & Hindricks, G. (2024) · Die Kardiologie · doi:10.1007/s12181-024-00678-9
Catheter Ablation of Arrhythmias
Ellis, E. R., Wylie, J. V., & Josephson, M. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24126-7.00086-7
Self-citationCardiac Rhythms and Cardiovascular Outcomes
Kreidieh, B., Keramati, A. R., & Kowey, P. R. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_15
Acute haemodynamic decompensation in the era of substrate-based ablation: rare but still worrisome
Liuba, I., de Chillou, C., & Santangeli, P. (2024) · EP Europace · doi:10.1093/europace/euae144
Spratt, M. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.250821 · Cited by 1
Ablation for Ventricular Tachycardia
Vajapey, R. S., & John, R. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00014-5
Bencardino, G., Narducci, M. L., Scacciavillani, R., Gabrielli, F., Pelargonio, G., Massetti, M., Crea, F., & Lanza, G. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164958
“…Tachycardia) showed that CA reduced ICD therapies in patients with ischemic heart disease and sustained VT, but had no effect on mortality [11]; similar results were obtained by the VTACH (Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter…”
ResultAblação robótica para taquicardia: análise à luz da literatura
Almeida, A. M. R. M., de Alencar, S. R. A., da Cunha, L. A., Lamounier, A. F., Oliveira, G. F., Bezerra, G. N., de Vasconcelos, L. M., Gonçalves, A. D. C., Soares, T. S., & Bispo, C. P. (2024) · STUDIES IN HEALTH SCIENCES · doi:10.54022/shsv5n3-048
Substrate-Based Ablation for Ventricular Tachycardia
Garg, L., & Tzou, W. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93110-6.00036-0
Technologic Advances in Cardiac Electrophysiology
Piccini, J. P., & Grant, A. O. (2024) · Circulation · doi:10.1161/circulationaha.124.071542
Mizutani, Y., Yanagisawa, S., & Inden, Y. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.13211
“2,3 Previous studies have demonstrated inferior outcomes following VT ablation in patients with NICM compared to those with ICM, possibly because of the heterogenous VT substrate in patients with NICM.”
Stellenwert der Ablation ventrikulärer Tachykardien bei Patienten mit systolischer Herzinsuffizienz
Ebert, M., Thomsen, Y., & Richter, S. (2025) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-024-01064-4
Gonçalves, A., Gonçalves, L. M. M., & Pinto, F. J. (2025) · Imprensa da Universidade de Coimbra eBooks · doi:10.14195/978-989-26-2420-4
AbdelWahab, A. M., Kuriachan, V. P., Mitchell, L. B., & Sapp, J. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00040-6
Pace-mapping Methods for Scar-related Ventricular Tachycardia
Hanaki, Y. (2025) · Japanese Journal of Electrocardiology · doi:10.5105/jse.45.87
Der erste ICD(implantierbarer Kardioverter-Defibrillator)-Schock
Kleemann, T., & Zahn, R. (2025) · Herz · doi:10.1007/s00059-025-05338-6
VT-Ablation als Alternative zum Defibrillator: Wer ist ein Kandidat?
Maagh, P., Kluthke, R., & Perings, C. A. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2666-3126
Seagren, A., Lancini, D. V., Ni, Z., Sapp, J. L., AbdelWahab, A. M., & Zhou, S. (2025) · Annals of Biomedical Engineering · doi:10.1007/s10439-025-03927-4
Ventricular Heart Rhythm Disorders
Steven, D., Scheurlen, C., Dittrich, S., Filipovic, K., van den Bruck, J., & Sultan, A. (2025) · Springer eBooks · doi:10.1007/978-3-662-69938-6_4
Katheterablation bei elektrischem Sturm
Wißner, E., & Reißmann, B. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0313-y
Makimoto, H., Zielke, S., Clasen, L., Lin, T., Gerguri, S., Müller, P., Schmidt, J., Bejinariu, A., Kurt, M., Brinkmeyer, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11999163
Blasinger, D. (2019) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Kazui, S., & Kazui, S. (2024) · UA Campus Repository (The University of Arizona)
NISI, X. (2017) · Electronic Theses and Dissertations Repository (University of Pisa)
Advances in Antiarrhythmic Drug Therapy
Olleik, F., & Kowey, P. R. (2025) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2025.10.006
Approach to Ventricular Arrhythmias in Heart Failure
Keithler, A. N., & Konstantinidis, K. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.11.003
Tondo, C., Brignole, M., & Fraticelli, A. (2008) · Giornale italiano di cardiologia · doi:10.1714/651.7596
Al‐Shammari, A. S., Singla, A., Rao, A., Sakini, A. S. A., Awashra, A., Khan, M., Mutar, M. T., Hamzah, K. A., Al‐Kaisey, A., Taii, H. A., et al. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70273
Ablation ventrikulärer Tachykardien
Ebert, M., & Richter, S. (2026) · Die Kardiologie · doi:10.1007/s12181-026-00801-y
Chourrout, G., Gal, F. L., & Degand, B. (2026) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2026.02.006
Ventricular Arrhythmias and Heart Failure
Keane, S., Ellis, E. R., Josephson, M. E., & Callans, D. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-12626-9_21
Self-citationBussmann, B. M., George, B., Robinson, M., Grist, J. T., Sukumar, P., Chinherende, E., Sheerin, F., Enzhil, V., Rider, O. J., Jones, B., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110958
Doldi, F., Meyer, C., Brachmann, J., Kreimer, F., Lewalter, T., Tilz, R., Kuniss, M., Akin, I., Sommer, P., Riemer, T., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13030134
Korobchenko, L. E., Gasimova, N. Z., Lebedev, D. S., & Mikhaylov, E. N. (2026) · Journal of Arrhythmology · doi:10.35336/va-1582
Karkowski, G., Rydlewska, A., Ząbek, A., Ulman, M., Baran, M., Lelakowski, J., & Kuniewicz, M. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70226
Lozoya, R. C. (2015) · theses.fr (ABES) · doi:10.70675/dc75b943z939fz4b91z9a9fza3a008e8212d · Cited by 2
Sroubek, J., Baranowski, B. J., Bhargava, M., Callahan, T. D., Chung, M. K., Chung, R., Dresing, T., Higuchi, K., Hussein, A. A., Kanj, M. H., et al. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.04.008
Kovacs, B., Dinshaw, L., Castillo, A. M. D., Jungen, C., Kurath-Koller, S., Stojković, S., Santoro, F., Mugnai, G., Perrotta, L., ter Bekke, R. M. A., et al. (2026) · CJC Open · doi:10.1016/j.cjco.2026.04.009
Elnashar, M., Abdelsayed, K., Mohamed, A. E., Abomohsen, M., Gadelmawla, A. F., Kholeif, Z. M., Almakadma, A. H., Tahhan, I. S., Rashwan, R., Elnady, M., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001294
Dinshaw, L. (2026) · Deutsches Ärzteblatt · doi:10.3238/perskardio.2026.05.29.02
Beyond the ICD: Navigating Ventricular Tachycardia Suppression Strategies in the Modern Era
Basso, T., AbdelWahab, A. M., & Sapp, J. L. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02380-6
“Typically, CSD is utilised as a ‘bailout’ strategy in cases where acute suppression cannot be achieved by conventional means [ 70 ].”
Heart Rhythm 2026: Innovations shaping the future of electrophysiology
Mi, J., & Gopinathannair, R. (2026) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2026.06.010
Santoro, F., Perrotta, L., & Mugnai, G. (2026) · EP Europace · doi:10.1093/europace/euag141
Wang, X., Mayer, J., Dennis, A. S., CHOW, A. W. C., Al-Sheikhli, J., Siang, R., Winter, J., O’Shea, C., Dhanjal, T., Lambiase, P. D., et al. (2026) · medRxiv · doi:10.64898/2026.06.08.26354989
Griné, M., Costa, G., & Sousa, P. A. (2026) · EP Europace · doi:10.1093/europace/euag077
“4,5 In Table 1, SMASH-VT is described as comparing ‘ICD plus prophylactic ablation’ with ‘ICD plus AAD’.”
Kreimer, F., Wolfes, J., Riemer, T., Senges, J., Perings, C. A., Tilz, R. R., Akın, İ., Meyer, C., Kleemann, T., Kuniss, M., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02973-9
Approach to Ventricular Arrhythmias in Heart Failure
Keithler, A. N., & Konstantinidis, K. (2026) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2026.06.011
Hashimoto, K., Turnbull, S., & Kumar, S. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70488
Marco, C. D., Hadjis, A. E., Saint-Phard, W., & Raymond, J. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm52698
“In the SMASH-VT study [17], patients with prior myocardial infarction undergoing secondary prevention ICD implantation who were randomized to prophylactic substrate-based VT ablation experienced significantly fewer ICD therapies compared with those receiving ICD implantation alone.”
Komatsu, Y., & Nogami, A. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm51668
“Scar-related ventricular tachycardia (VT) remains a major cause of lethal arrhythmias in patients with both ischemic and nonischemic cardiomyopathies, and catheter ablation has become an essential therapeutic option for cases refractory to antiarrhythmic drug therapy [ 1,2,3,4].”
Garnica, D., Bautista, H., Isaac, R., Nudelman, J., Rojas-Marulanda, J., Pisciotti, S. L., Giraldo-Ramírez, S., Sáenz, L. C., Romero, J., & Tapias, C. A. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134775
Malinowski, J., Nowotka, Ł., Rokicki, J. K., Woźniak, O., Syska, P., Lewandowski, M., Oręziak, A., Zakrzewska‐Koperska, J., Marchewka, P., Jargieło, A., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187128
“…zones and delays alone altered appropriate therapy rates several-fold [19–23], antitachycardia pacing terminates the majority of fast ventricular tachycardias that would otherwise be shocked [24–26], and both catheter ablation and amiodarone substantially reduce subsequent device therapies [27–32].”
Katheterablation ventrikulärer Tachykardien – DGK-Empfehlung
Rillig, A., Deneke, T., Arya, A., Ebert, M., Hansen, C., Sultan, A., & Eckardt, L. (2026) · Die Kardiologie · doi:10.1007/s12181-026-00838-z
Yamamoto, T., Sroubek, J., Lee, J., Baranowski, B. J., Bhargava, M., Callahan, T. D., Chung, M., Courson, J. P., Dresing, T., Hussein, A. A., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.09.052
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.